US FDA Would See Another Austere Year With GOP Funding Bill, No PRV Reauthorization

Democrats are raising concerns that the continuing resolution intended to fund the government for the remainder of fiscal year 2025 gives Trump too much power, though it is unclear whether the FDA would be as impacted as other agencies.